GET DAILY SIGNALSEdgewell Personal Care (EPC) Delivers Steady Q4 Results as Turnaround Efforts Take Hold
Key Takeaways
- Edgewell reported fiscal fourth-quarter adjusted earnings of $0.78 per share, edging past the consensus estimate of $0.77.
- Net sales rose 3% year over year to $484.1 million, ahead of Wall Street's roughly $479.9 million forecast, with organic sales up 3.1%.
- Adjusted gross margin expanded 510 basis points to 45.7%, while adjusted EBITDA climbed to $76.8 million from $43 million a year earlier.
- Both North America (up 3.3%) and International (up 3.0%) returned to organic growth, and the company swung to a GAAP profit of $0.23 per share from a prior-year loss.
- Fiscal 2027 guidance calls for adjusted EPS of $1.85 to $2.15 and organic net sales growth of 1% to 3%, though free cash flow is expected to remain light.
- For more detail on Edgewell's Major News, Today's Price Move, Price Targets, and Forecast, explore the dedicated ticker pages.
- Discover actionable trade ideas with Trending AI Robots to complement your earnings analysis.
Why These Results Matter in the Broader Turnaround Story
Edgewell Personal Care Company (EPC), known for brands like Schick razors, Banana Boat sunscreen, and Billie grooming products, continues its multi-year shift following the divestiture of its Feminine Care business. Fiscal 2026 involved significant restructuring, notably the consolidation of its North American wet shave manufacturing footprint. The fourth-quarter results stand out because they provide the clearest indication yet that the turnaround is progressing: organic growth returned in both regions, and gross margin recovered sharply after three consecutive quarters of decline. In my view, these figures help confirm whether the company's focus on cost efficiency and brand investment can translate into sustained, profitable growth in fiscal 2027.
Breaking Down the Reported Figures
For the fiscal fourth quarter ended September 2026, EPC delivered adjusted EPS of $0.78, above the $0.77 consensus and up from $0.52 in the prior year on a continuing-operations basis. Net sales climbed 3.0% to $484.1 million, exceeding expectations of about $479.9 million. Organic net sales advanced 3.1%, supported by a 3.3% increase in North America and a 3.0% rise internationally. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Profitability metrics improved notably. Adjusted gross margin widened 510 basis points to 45.7%, helped by productivity gains, better volume absorption, and currency effects. Adjusted EBITDA rose to $76.8 million from $43 million a year earlier. On a GAAP basis, the company posted net income of $10.9 million, or $0.23 per diluted share from continuing operations, versus a loss of $30.6 million, or $0.66 per share, in the prior period. The adjusted results benefited from roughly $0.11 of favorable currency and transition-services income related to the divestiture.
Management's fiscal 2027 outlook includes adjusted EPS of $1.85 to $2.15, organic net sales growth of 1% to 3%, revenue between $2.004 billion and $2.044 billion, adjusted EBITDA of $250 million to $270 million, and adjusted free cash flow of $100 million to $120 million.
Market Reaction and Sentiment Following the Release
Shares of EPC remained largely flat in premarket trading after the report, as the results aligned closely with expectations on the surface. The modest EPS beat and revenue upside were tempered by factors such as a significant currency tailwind, transition-services income, and a softer free cash flow outlook for the coming year. Investor sentiment appears cautiously optimistic, with the stock nearing its 52-week high and management sounding more confident on the call, pointing to distribution gains, U.S. branded unit-share improvements, and ongoing momentum at Cremo and Billie.
Key Factors to Watch in the Year Ahead
Looking forward, the fiscal 2027 guidance suggests measured improvement, with organic sales growth of 1% to 3% expected across segments and regions, plus roughly 70 basis points of operating-margin expansion from gross-margin gains and lower SG&A expenses. Several elements deserve close attention. The company anticipates about 300 basis points of energy-driven inflation plus ongoing tariff costs, which it aims to offset through productivity and pricing actions. The North American wet shave manufacturing consolidation timeline has shifted by roughly six months, deferring related savings into fiscal 2028. Brand-specific developments, such as the Banana Boat relaunch, a major Billie innovation push, and a return to growth in private-label shave during the second half, will also be important to monitor. In addition, the end of transition-services income and a higher tax rate could pressure earnings below the line, making operating leverage and cash-flow conversion key metrics to track.
Using Tickeron Tools to Support My Research
One tool I turn to regularly for earnings analysis is Tickeron’s AI Screener. It helps me quickly filter stocks and ETFs based on technical patterns, fundamentals, and AI-driven signals, making it easier to compare names like EPC against peers and identify potential opportunities without spending hours on manual screens. I find it especially useful when evaluating consumer staples companies during earnings season.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
EPC in -5.63% downward trend, declining for three consecutive days on November 06, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where EPC declined for three days, in 182 of 295 cases, the price declined further within the following month. The odds of a continued downward trend are 62%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 59 cases where EPC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 61%.
EPC broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on EPC as a result. In 50 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.
The Moving Average Convergence Divergence (MACD) for EPC just turned positive on October 29, 2026. Looking at past instances where EPC's MACD turned positive, the stock continued to rise in 26 of 42 cases over the following month. The odds of a continued upward trend are 62%.
EPC moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for EPC crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 59%.
Following a +5.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where EPC advanced for three days, in 211 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The Aroon Indicator entered an Uptrend today. In 147 of 228 cases where EPC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 19 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.884) is normal, around the industry mean (21.731). P/E Ratio (-14.065) is within average values for comparable stocks, (16.288). EPC's Projected Growth (PEG Ratio) (3.530) is slightly higher than the industry average of (1.518). Dividend Yield (0.021) settles around the average of (0.032) among similar stocks. P/S Ratio (0.554) is also within normal values, averaging (1.902).
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. EPC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EPC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a maker of skin care and other personal care products
Industry HouseholdPersonalCare
Advertisement